Latest News about INCY
Recent news which mentions INCY
XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
March 23, 2025
From Benzinga
Tesla To $320? Here Are 10 Top Analyst Forecasts For Tuesday
March 18, 2025
From Benzinga
From Benzinga
Incyte's New Treatment for Chronic Skin Disease Shows Promising Results In Latest Clinical Trials, Stock Falls
March 17, 2025
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 17, 2025
From Benzinga
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
March 17, 2025
From Benzinga
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
March 11, 2025
From Benzinga
Incyte Releases Mixed Data From Late-Stage Opzelura Studies In Skin Disease Characterized By Itchy Firm Lumps
March 10, 2025
From Benzinga
Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?
February 10, 2025
From Benzinga
Incyte Q4 Earnings: EPS Miss, Strong Jakafi And Opzelura Sales, Says 2025 To Be Catalyst Rich Including 4 Launches
February 10, 2025
From Benzinga
Earnings Scheduled For February 10, 2025
February 10, 2025
From Benzinga
Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline
January 14, 2025
From Benzinga
From Motley Fool
Target, Alibaba And Temu Parent PDD Are Among Top 10 Large-Cap Losers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
November 24, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 19, 2024
From Benzinga
Gold Moves Higher; Medtronic Posts Upbeat Results
November 19, 2024
From Benzinga
Stocks Move Higher, Walmart Hits Record High, Natural Gas Reaches 5-Month Peak: What's Driving Markets Tuesday?
November 19, 2024
From Benzinga
What's Going On With Incyte Shares Tuesday?
November 19, 2024
From Benzinga
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
November 19, 2024
From Benzinga
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
November 19, 2024
From Benzinga
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views
November 19, 2024
From Benzinga
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
November 19, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Incyte
November 14, 2024
Tickers
INCY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.